91大神

91大神 Children's Health | 听

Skip to Content on 91大神.org
# #

    Meet Our Team

    Learn more about our physician researchers, clinicians and scientists.

    Find a Researcher

    Partner With Us

    Join forces with our world-class research teams. Whether in academia, industry, or health care, let鈥檚 advance children鈥檚 health together.

    Learn How
    Partnerships

    Study With Us

    Our research fellows directly impact the work we do. See our education opportunities and join us.

    Apply Now

    Join Our Team

    Shape the future of pediatric medicine through groundbreaking research. Explore our research opportunities.

    View Positions
    Find a Researcher

    Ricki S. Carroll, MD

    Physician
    Provider Profile

    91大神 Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803

    Fellowship

    • Palliative Care - Alfred I. duPont Hospital for Children, 2019

    Residency

    • General Pediatrics - The Children's Hospital of Philadelphia, 2015

    Education

    • M.D. - University of Pennsylvania School of Medicine, 2012

    Board Certifications

    • American Board of Pediatrics/General Pediatrics
    • American Board of Pediatrics/Hospice & Palliative Medicine

    • Biomarkers
    • Lethal
    • Osteogenesis Imperfecta
    • Skeletal Dysplasia

    • Survivorship of Individuals With Double Heterozygosity for Achondroplasia and Type 2 Collagenopathy; American Journal of Medical Genetics Part A; (2025).

    • Approach to the Patient with Achondroplasia鈥擭ew Considerations for Diagnosis, Management, and Treatment; The Journal of Clinical Endocrinology & Metabolism; (2025).

    • C-type natriuretic peptide and collagen X marker are aberrant in skeletal dysplasias; Journal of Bone and Mineral Research; (2025).

    • Author Correction: Specific heterozygous variants in MGP lead to endoplasmic reticulum stress and cause spondyloepiphyseal dysplasia; Nature Communications; (2024).

    • Vosoritide Therapy in Children with Achondroplasia: Early Experience and Practical Considerations for Clinical Practice; Advances in Therapy; (2024).

    • Identification of potential non-invasive biomarkers in diastrophic dysplasia.; Bone; (2023).

    • Specific heterozygous variants in MGP lead to endoplasmic reticulum stress and cause spondyloepiphyseal dysplasia; Nature Communications; (2023).

    • Trends in Serum Cytokine Expression in Pediatric Skeletal Dysplasia; JBMR Plus; (2023).

    • Collagen X Marker Levels are Decreased in Individuals with Achondroplasia; Calcified Tissue International; (2022).

    • An Informed Approach to Vaccine Hesitancy and Uptake in Children.; Delaware journal of public health; (2022).

    • Microcephalic osteodysplastic primordial dwarfism type II is associated with global vascular disease.; Orphanet journal of rare diseases; (2021).

    • Comprehensive pain management strategy for infants with moderate to severe osteogenesis imperfecta in the perinatal period; Paediatric and Neonatal Pain; (2021).

    • End-of-life medical decision-making for children in custody: A collaborative, multi-stakeholder practical approach.; Child abuse & neglect; (2020).

    • Should We Stop Calling Thanatophoric Dysplasia a Lethal Condition? A Case Report of a Long-Term Survivor.; Palliative medicine reports; (2020).

    • Motivations of patients with pulmonary arterial hypertension to participate in randomized clinical trials.; Clinical trials (London, England); (2012).

    • Sudden Unexpected Infant Death: A Compassionate Forensic Approach to Care; Clinical Pediatric Emergency Medicine; (2012).